Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
21 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Medicis Pharmaceutical Articles
Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion
4 September 2012
Hyperion gets rights to Ravicti, and perhaps more, from Ucyclyd
25 March 2012
Medicis and Anacor collaborate on acne drug development in up to $160 million deal
11 February 2011
Mylan/Matrix launch generic Solodyn in USA; settlement with Medicis
26 July 2010
Showing 1-4 of 4 articles
1
Hot Topics
Most Read
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
Elan makes "transformational" acquisitions and a divestment
HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
Is failure to adopt business process management putting the pharma industry at risk?
Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
Elan makes "transformational" acquisitions and a divestment
HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
Is failure to adopt business process management putting the pharma industry at risk?
Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law